AstraZeneca in Gaithersburg

  • GAITHERSBURG, MARYLAND
  • USA

Pushing the boundaries of science

The modern, vibrant, scientific campus employs more than 3,000 experts in our field and is only a short drive from Washington, DC.

Explore Gaithersburg

Research laboratories

Filled with cutting-edge technology, our lab spaces were created to facilitate collaboration, interaction and cross-functional science.

Open space

Our newly-designed activity-based work spaces suit a variety of working styles while increasing collaboration and interaction between teams. We've brought our science directly into our renovated work spaces and made it central to our design.

Work/life balance

We believe employees benefit from being invigorated, challenged and inspired at work. We offer everything from beanbag rooms for creative brainstorming, game rooms and Zen gardens to treadmill stations, onsite massage and regular campus happy hours.

Sustainability

We take pride in our mission to produce innovative, life-saving medications and our commitment to pursue this mission in a sustainable manner. Our Gaithersburg Campus is committed to our Ambition Zero Carbon initiative, integrating energy improvement strategies into our facilities, operations, design, and procurement practices through the ISO 50001 Energy Management System. We are tackling climate action now by setting and tracking aggressive energy targets to foster healthy people and a healthy planet.

Amenities

We offer a variety of amenities to help boost productivity and keep our employees happy and healthy. These include our fitness center, employee healthcare clinic, electric vehicle charging stations, dry cleaning, full service cafeteria, and copy center.

Gaithersburg key facts

>3,500

Employees in Gaithersburg

>1 billion USD

Research and development annual spend

>10,000 square feet

Employee fitness center

Our capabilities

Target biology

 

Our team of world-renowned scientists collaborate to support the identification and validation of targets regulating biological processes which are the fundamental drivers of human disease. Using a variety of tools, including in vivo and in vitro assays and bio-informatic approaches, our scientists rigorously test biological hypotheses across our focus areas.

Protein engineering

 

Our Antibody Discovery and Protein Engineering Department applies cutting-edge technologies in the discovery of novel therapeutic biologics to change the lives of patients. The team works collaboratively across all therapy areas and deploys a plethora of innovative in-house platform technologies such as phage and ribosome display, Fc engineering, and novel peptide discovery methodologies. We have an exceptional track record of delivery, having discovered and engineered approaching 100 protein therapeutics that have entered the clinic.

Translational science

 

Our translational expertise enables us to accelerate drug development in human disease by selecting the right patients in early clinical trials. We accomplish this by embedding human target validation earlier in research, utilising innovative clinical trial design approaches and integrating multiple, relevant scientific insights across our focus areas.

Personalised healthcare

 

As a leader in personalised healthcare, we are committed to matching new medicines to the patient most in need. We combine industry-leading expertise in companion diagnostics with laboratory science in molecular diagnostics, tissue diagnostics, imaging and protein biomarkers, and we work collaboratively with our external partners to harness breakthrough technologies across the life-cycle of our medicines.

Biopharmaceutical development

 

Our Biopharmaceutical Development team develops the process and analytics to produce and characterise product candidates, including the formulations and drug product forms, for delivering medicines to patients. Working closely with research, the team helps define and select the best product candidates to progress into development.

Clinical development

 

Our Early Clinical Development team designs and delivers early phase development strategies and exploratory studies that build the credentials of novel targets. Clinical Operations delivers global clinical trials for late stage projects across our pipeline, using both internal and external programme and study management expertise. Our teams are especially experienced in cardiovascular and respiratory diseases and in managing large outcome studies in partnership with Academic Research Organisations.